Corporate News 12-Nov-22
Natco Pharma named a defendant in an antitrust lawsuit in US
In a matter related to Lenalidomide (Revlimid)
Natco Pharma announced that Bristol Myers Squibb, Teva, and Natco have been named defendants in an antitrust lawsuit in the US by Walgreens Co. regarding Lenalidomide (Revlimid). Natco believes this matter is without merit. Teva is the ANDA holder and front-end marketing partner for the generic product in the US.
Previous News
Natco Pharma consolidated net profit rises 241.41% in the December 2023 quarter
( Results - Announcements 15-Feb-24 16:17 )
Natco Pharma
( Results - Analysis 10-Aug-23 10:40 )
Natco Pharma Ltd rises for third consecutive session
( Hot Pursuit - 24-Jul-24 13:05 )
Natco Pharma Ltd soars 1.76%, Gains for third straight session
( Hot Pursuit - 08-Aug-24 13:05 )
Natco Pharma schedules board meeting
( Corporate News - 03-Feb-24 17:07 )
Natco Pharma to hold AGM
( Corporate News - 06-Sep-23 17:31 )
Natco Pharma temporarily shuts operations at Chennai-based plant
( Hot Pursuit - 07-Dec-23 15:14 )
Natco Pharma fixes record date for interim dividend
( Market Beat - Reports 09-Aug-22 18:51 )
Natco Pharma Ltd spurts 5.12%, rises for fifth straight session
( Hot Pursuit - 11-Jun-24 13:00 )
Natco Pharma Ltd rises for third consecutive session
( Hot Pursuit - 02-Nov-21 13:05 )
Natco Pharma gains on favourable verdict in CTPR patent infringement case
( Hot Pursuit - 06-Dec-22 10:01 )
Other Stories
Knowledge Marine wins work order for Dredging Corporation of India
03-Oct-24 12:35
Board of Bajaj Steel approves bonus issue of 3:1
03-Oct-24 12:33
NIIT allots 75,000 equity shares under ESOP
03-Oct-24 12:01
Five-Star Business Finance allots 10,120 equity shares under ESOP
03-Oct-24 12:00
J Kumar Infraprojects bags MMRDA road project of Rs 1847.72 cr
03-Oct-24 11:53
EFC announces incorporation of two new step down subsidiaries
03-Oct-24 11:43
Utkarsh Small Finance Bank appoints Mary Kom and Sunil Chhetri as its brand ambassadors
03-Oct-24 11:41
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Back
Top
